The medication side of ICU nutrition: recognize refeeding risk before calories start, give thiamine when indicated, correct phosphate/potassium/magnesium safely, control glucose without starving the patient, and count non-nutritional calories such as propofol lipid.
Identify refeeding-risk patients before aggressive carbohydrate delivery.
Use thiamine promptly in Wernicke risk and around refeeding without delaying emergency glucose for severe hypoglycemia.
Treat phosphate, potassium and magnesium deficits as linked physiology rather than isolated lab values.
Use insulin to control persistent hyperglycemia while continuing appropriate nutrition rather than repeatedly stopping feeds.
Count propofol lipid calories and avoid overfeeding while maintaining adequate protein strategy.
Full enteral/parenteral nutrition strategy and monitoring.
The table below is a selection framework. Open the individual monograph for exact dosing, preparation, renal/CRRT/IHD adjustment, interactions and evidence traceability.
ICU role: Essential B1 cofactor for carbohydrate metabolism and Wernicke prevention/treatment.
Monitor: Neurologic response, magnesium and refeeding electrolytes.
ICU role: Concentrated IV glucose for immediate severe hypoglycemia rescue.
Monitor: Glucose within minutes, neurologic status and IV site.
ICU role: Titrated insulin for ICU hyperglycemia and selected metabolic emergencies.
Monitor: Hourly glucose during titration, potassium and nutrition delivery.
ICU role: Magnesium replacement and disease-specific emergency therapy.
Monitor: Mg, renal function, reflexes/respiration with large exposure.
ICU role: Combined phosphate + potassium replacement for selected depleted patients.
Monitor: Phosphate, K, ionized Ca, renal function and ECG when substantial K is delivered.
ICU role: Sedative delivered in a lipid emulsion that contributes meaningful non-nutritional calories.
Monitor: Triglycerides according to exposure/risk, CK/lactate/acid-base when PRIS suspected and total calories.
| Agent | ICU role | Why I choose it | Why I hesitate | What I monitor |
|---|---|---|---|---|
| Thiamine Water-Soluble Vitamin / Metabolic Cofactor | Essential B1 cofactor for carbohydrate metabolism and Wernicke prevention/treatment. | ✓ Suspected Wernicke encephalopathy and high-risk refeeding/malnutrition states. | ✕ Do not rely on one low prophylactic dose for established Wernicke; do not delay life-saving dextrose in severe hypoglycemia. | Neurologic response, magnesium and refeeding electrolytes. |
| Dextrose 50% in Water (D50W) Hypertonic IV Glucose | Concentrated IV glucose for immediate severe hypoglycemia rescue. | ✓ Severe symptomatic hypoglycemia with secure IV access when rapid concentrated rescue is needed. | ✕ Hypertonic extravasation injury and rebound hyperglycemia; D10 often allows safer titration. | Glucose within minutes, neurologic status and IV site. |
| Regular Insulin (IV) Rapid-Onset IV Insulin — Endogenous Peptide Hormone | Titrated insulin for ICU hyperglycemia and selected metabolic emergencies. | ✓ Persistent ICU hyperglycemia or DKA/HHS protocol after potassium and fluid issues are addressed. | ✕ Nutrition interruption or renal recovery can rapidly change insulin requirement and cause hypoglycemia. | Hourly glucose during titration, potassium and nutrition delivery. |
| Magnesium Sulfate Electrolyte / Multi-Mechanism Membrane & Neuromuscular Modulator | Magnesium replacement and disease-specific emergency therapy. | ✓ Correct clinically important hypomagnesemia, especially when hypokalemia is refractory or arrhythmia risk is present. | ✕ Renal failure increases hypermagnesemia and respiratory/neuromuscular toxicity. | Mg, renal function, reflexes/respiration with large exposure. |
| Potassium Phosphate IV Phosphate and Potassium Replacement | Combined phosphate + potassium replacement for selected depleted patients. | ✓ Refeeding or other hypophosphatemia when potassium is also low and IV replacement is indicated. | ✕ Avoid when potassium is high or renal clearance is poor; rapid/excess phosphate can cause hypocalcemia and calcium-phosphate precipitation. | Phosphate, K, ionized Ca, renal function and ECG when substantial K is delivered. |
| Propofol Intravenous Sedative-Hypnotic Agent | Sedative delivered in a lipid emulsion that contributes meaningful non-nutritional calories. | ✓ When propofol is the best sedative, count its lipid calories in the nutrition prescription rather than stopping necessary sedation. | ✕ Overfeeding/hypertriglyceridemia and PRIS risk at high/prolonged exposure. | Triglycerides according to exposure/risk, CK/lactate/acid-base when PRIS suspected and total calories. |
Why: This is a high-risk refeeding phenotype.
Why: Nutrition interruption is a common preventable cause of ICU hypoglycemia.
Why: Replacement salt must fit the concurrent potassium/renal physiology.
Why: Propofol provides 1.1 kcal/mL from lipid emulsion.
Recognition becomes selection, then organ-failure adjustment, competing physiology and senior-level prioritization.
Malnourished patient with confusion, gait ataxia and ophthalmoplegia.
Treat suspected Wernicke immediately with high-dose IV thiamine and correct magnesium; do not wait for a thiamine level.
Severely malnourished patient begins enteral feeding and phosphate falls sharply overnight.
Recognize refeeding physiology: slow caloric escalation as needed, replace phosphate/K/Mg and continue thiamine with frequent monitoring.
Insulin infusion 4 U/h; feeds are stopped for bronchoscopy and glucose falls to 3.1 mmol/L.
Stop/reduce insulin per protocol, treat hypoglycemia with dextrose, and create a feed-interruption insulin plan before restarting.
Anuric patient on intermittent HD has phosphate 0.45 mmol/L, K 5.2 and severe weakness.
Do not give potassium-phosphate. Use renal/pharmacy-guided non-potassium phosphate replacement and coordinate with dialysis timing and ionized calcium monitoring.
Obese ventilated patient receives high-dose propofol plus PN at full predicted calories; triglycerides rise and CO2 production is high.
Count propofol lipid energy, reassess measured/predicted energy provision and PN nonprotein calories, preserve appropriate protein delivery and review the ongoing need/dose of propofol.
Essential vitamin cofactor used urgently when Wernicke encephalopathy is suspected and prophylactically in patients at high risk of refeeding syndrome or severe deficiency. Give before or with carbohydrate, but do not delay treat…
Concentrated IV glucose for severe symptomatic hypoglycemia when rapid IV rescue is required. Because D50W is markedly hypertonic and can cause tissue injury if extravasated, many ICUs prefer titrated D10W when time and access al…
IV regular insulin is used for distinct ICU purposes — DKA, HHS/mixed hyperglycemic crisis, temporizing potassium shift in hyperkalemia, and general ICU glycemic control — each with different dosing and endpoints; insulin SHIFTS …
Spans four genuinely distinct ICU indications — torsades de pointes, adjunctive severe asthma therapy, eclampsia/severe preeclampsia, and simple hypomagnesemia repletion — each with its own mechanism-relevant dosing; no single do…
Concentrated IV phosphate replacement that also delivers a substantial potassium load. Use when clinically important hypophosphatemia requires IV therapy and concurrent potassium status permits; renal dysfunction and hyperkalemia…
Rapid-onset, short-acting IV sedative-hypnotic for mechanical ventilation sedation and ICP control — lowers cerebral metabolic demand ($CMRO_2$) but risks severe hypotension and Propofol Infusion Syndrome (PRIS).
This Masterclass teaches selection and reasoning. Exact dosing, concentration, infusion preparation, renal/hepatic/RRT adjustment and monitoring must be checked in the linked medication monograph and the institution's current formulary/protocol. Local resistance patterns and regulatory drug availability can change faster than a static teaching page.